{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:33:26Z","timestamp":1794854006608,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:00:00Z","timestamp":1506556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:00:00Z","timestamp":1506556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/nrrheum.2017.155","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T22:47:32Z","timestamp":1506638852000},"page":"639-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":590,"title":["Inflammation in gout: mechanisms and therapeutic targets"],"prefix":"10.1038","volume":"13","author":[{"given":"Alexander K.","family":"So","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Martinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,28]]},"reference":[{"key":"BFnrrheum2017155_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo, C. F., Grainge, M. J., Zhang, W. & Doherty, M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat. Rev. Rheumatol. 11, 649\u2013662 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2017155_CR2","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth, N., Merriman, T. R. & Stamp, L. K. Gout. Lancet 388, 2039\u20132052 (2016).","journal-title":"Lancet"},{"key":"BFnrrheum2017155_CR3","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle, D. & McDermott, M. F. A proposed classification of the immunological diseases. PLoS Med. 3, e297 (2006).","journal-title":"PLoS Med."},{"key":"BFnrrheum2017155_CR4","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1172\/JCI29404","volume":"116","author":"F Martinon","year":"2006","unstructured":"Martinon, F. & Glimcher, L. H. Gout: new insights into an old disease. J. Clin. Invest. 116, 2073\u20132075 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2017155_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407\u2013420 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2017155_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro-IL-\u03b2. Mol. Cell 10, 417\u2013426 (2002).","journal-title":"Mol. Cell"},{"key":"BFnrrheum2017155_CR7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2014.01.063","volume":"156","author":"X Cai","year":"2014","unstructured":"Cai, X. et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156, 1207\u20131222 (2014).","journal-title":"Cell"},{"key":"BFnrrheum2017155_CR8","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1172\/JCI28075","volume":"116","author":"CJ Chen","year":"2006","unstructured":"Chen, C. J. et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116, 2262\u20132271 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2017155_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.it.2017.01.003","volume":"38","author":"RA Aglietti","year":"2017","unstructured":"Aglietti, R. A. & Dueber, E. C. Recent insights into the molecular mechanisms underlying pyroptosis and gasdermin family functions. Trends Immunol. 38, 261\u2013271 (2017).","journal-title":"Trends Immunol."},{"key":"BFnrrheum2017155_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/rheumatology\/kev339","volume":"55","author":"A Abhishek","year":"2016","unstructured":"Abhishek, A. et al. In vivo detection of monosodium urate crystal deposits by Raman spectroscopy \u2014 a pilot study. Rheumatology (Oxford) 55, 379\u2013380 (2016).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2017155_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666\u2013671 (2015).","journal-title":"Nature"},{"key":"BFnrrheum2017155_CR12","doi-asserted-by":"publisher","first-page":"10274","DOI":"10.1038\/ncomms10274","volume":"7","author":"SR Mulay","year":"2016","unstructured":"Mulay, S. R. et al. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat. Commun. 7, 10274 (2016).","journal-title":"Nat. Commun."},{"key":"BFnrrheum2017155_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.immuni.2012.01.012","volume":"36","author":"JE Vince","year":"2012","unstructured":"Vince, J. E. et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36, 215\u2013227 (2012).","journal-title":"Immunity"},{"key":"BFnrrheum2017155_CR14","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/art.21238","volume":"52","author":"R Liu-Bryan","year":"2005","unstructured":"Liu-Bryan, R., Scott, P., Sydlaske, A., Rose, D. M. & Terkeltaub, R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 52, 2936\u20132946 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017155_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"BFnrrheum2017155_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0952-7915(02)00017-1","volume":"15","author":"K Burns","year":"2003","unstructured":"Burns, K., Martinon, F. & Tschopp, J. New insights into the mechanism of IL-1\u03b2 maturation. Curr. Opin. Immunol. 15, 26\u201330 (2003).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrrheum2017155_CR17","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/art.38369","volume":"66","author":"D Holzinger","year":"2014","unstructured":"Holzinger, D. et al. Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout. Arthritis Rheumatol. 66, 1327\u20131339 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2017155_CR18","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LA Joosten","year":"2010","unstructured":"Joosten, L. A. et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 62, 3237\u20133248 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017155_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","volume":"12","author":"LA Joosten","year":"2016","unstructured":"Joosten, L. A., Abdollahi-Roodsaz, S., Dinarello, C. A., O'Neill, L. & Netea, M. G. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat. Rev. Rheumatol. 12, 344\u2013357 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2017155_CR20","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1002\/eji.201444560","volume":"44","author":"LL An","year":"2014","unstructured":"An, L. L. et al. Complement C5a potentiates uric acid crystal-induced IL-1\u03b2 production. Eur. J. Immunol. 44, 3669\u20133679 (2014).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2017155_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fphar.2017.00010","volume":"8","author":"HJ Khameneh","year":"2017","unstructured":"Khameneh, H. J. et al. C5a regulates IL-1\u03b2 production and leukocyte recruitment in a murine model of monosodium urate crystal-induced peritonitis. Front. Pharmacol. 8, 10 (2017).","journal-title":"Front. Pharmacol."},{"key":"BFnrrheum2017155_CR22","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","volume":"14","author":"V Petrilli","year":"2007","unstructured":"Petrilli, V. et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 1583\u20131589 (2007).","journal-title":"Cell Death Differ."},{"key":"BFnrrheum2017155_CR23","doi-asserted-by":"publisher","first-page":"e1954","DOI":"10.1038\/cddis.2015.277","volume":"6","author":"JR Yaron","year":"2015","unstructured":"Yaron, J. R. et al. K+ regulates Ca2+ to drive inflammasome signaling: dynamic visualization of ion flux in live cells. Cell Death Dis. 6, e1954 (2015).","journal-title":"Cell Death Dis."},{"key":"BFnrrheum2017155_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/art.33355","volume":"64","author":"FA Amaral","year":"2012","unstructured":"Amaral, F. A. et al. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout. Arthritis Rheum. 64, 474\u2013484 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017155_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He, Y., Zeng, M. Y., Yang, D., Motro, B. & Nunez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354\u2013357 (2016).","journal-title":"Nature"},{"key":"BFnrrheum2017155_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1074\/jbc.C115.700492","volume":"291","author":"JL Schmid-Burgk","year":"2016","unstructured":"Schmid-Burgk, J. L. et al. A genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J. Biol. Chem. 291, 103\u2013109 (2016).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2017155_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.3333","volume":"17","author":"H Shi","year":"2016","unstructured":"Shi, H. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. 17, 250\u2013258 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2017155_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519\u2013550 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum2017155_CR29","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1136\/ard.2010.128454","volume":"69","author":"N Schlesinger","year":"2010","unstructured":"Schlesinger, N. & Thiele, R. G. The pathogenesis of bone erosions in gouty arthritis. Ann. Rheum. Dis. 69, 1907\u20131912 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017155_CR30","first-page":"201","volume":"10","author":"CA Dinarello","year":"2004","unstructured":"Dinarello, C. A. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 10, 201\u2013222 (2004).","journal-title":"J. Endotoxin Res."},{"key":"BFnrrheum2017155_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","volume":"33","author":"MG Netea","year":"2015","unstructured":"Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W., Dinarello, C. A. & Joosten, L. A. Inflammasome-independent regulation of IL-1-family cytokines. Annu. Rev. Immunol. 33, 49\u201377 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum2017155_CR32","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.4049\/jimmunol.167.11.6568","volume":"167","author":"S Sugawara","year":"2001","unstructured":"Sugawara, S. et al. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. 167, 6568\u20136575 (2001).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017155_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1084\/jem.174.4.821","volume":"174","author":"H Mizutani","year":"1991","unstructured":"Mizutani, H., Schechter, N., Lazarus, G., Black, R. A. & Kupper, T. S. Rapid and specific conversion of precursor interleukin 1 beta (IL-1\u03b2) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174, 821\u2013825 (1991).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2017155_CR34","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.1998","volume":"15","author":"F Echtermeyer","year":"2009","unstructured":"Echtermeyer, F. et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat. Med. 15, 1072\u20131076 (2009).","journal-title":"Nat. Med."},{"key":"BFnrrheum2017155_CR35","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1084\/jem.181.5.1917","volume":"181","author":"M Irmler","year":"1995","unstructured":"Irmler, M. et al. Granzyme A is an interleukin 1\u03b2-converting enzyme. J. Exp. Med. 181, 1917\u20131922 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2017155_CR36","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4049\/jimmunol.1001284","volume":"186","author":"B Pazar","year":"2011","unstructured":"Pazar, B. et al. Basic calcium phosphate crystals induce monocyte\/macrophage IL-1\u03b2 secretion through the NLRP3 inflammasome in vitro. J. Immunol. 186, 2495\u20132502 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017155_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/BOR.0000000000000143","volume":"27","author":"A Dumusc","year":"2015","unstructured":"Dumusc, A. & So, A. Interleukin-1 as a therapeutic target in gout. Curr. Opin. Rheumatol. 27, 156\u2013163 (2015).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2017155_CR38","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1002\/art.39318","volume":"67","author":"LB Kienhorst","year":"2015","unstructured":"Kienhorst, L. B. et al. Gout is a chronic inflammatory disease in which high levels of interleukin-8 (CXCL8), myeloid-related protein 8\/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease. Arthritis Rheumatol. 67, 3303\u20133313 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2017155_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","volume":"75","author":"TO Crisan","year":"2016","unstructured":"Crisan, T. O. et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann. Rheum. Dis. 75, 755\u2013762 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017155_CR40","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1056\/NEJMoa035700","volume":"350","author":"HK Choi","year":"2004","unstructured":"Choi, H. K., Atkinson, K., Karlson, E. W., Willett, W. & Curhan, G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N. Engl. J. Med. 350, 1093\u20131103 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2017155_CR41","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1136\/annrheumdis-2011-201215","volume":"71","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Purine-rich foods intake and recurrent gout attacks. Ann. Rheum. Dis. 71, 1448\u20131453 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017155_CR42","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/art.39107","volume":"67","author":"AT Vieira","year":"2015","unstructured":"Vieira, A. T. et al. A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol. 67, 1646\u20131656 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2017155_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1189\/jlb.3A1015-453RRR","volume":"101","author":"AT Vieira","year":"2017","unstructured":"Vieira, A. T. et al. Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice. J. Leukocyte Biol. 101, 275\u2013284 (2017).","journal-title":"J. Leukocyte Biol."},{"key":"BFnrrheum2017155_CR44","doi-asserted-by":"publisher","first-page":"20602","DOI":"10.1038\/srep20602","volume":"6","author":"Z Guo","year":"2016","unstructured":"Guo, Z. et al. Intestinal microbiota distinguish gout patients from healthy humans. Sci. Rep. 6, 20602 (2016).","journal-title":"Sci. Rep."},{"key":"BFnrrheum2017155_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jare.2017.04.008","volume":"8","author":"G Ragab","year":"2017","unstructured":"Ragab, G., Elshahaly, M. & Bardin, T. Gout: an old disease in new perspective \u2014 a review. J. Adv. Res. 8, 495\u2013511 (2017).","journal-title":"J. Adv. Res."},{"key":"BFnrrheum2017155_CR46","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/annrheumdis-2015-208767","volume":"75","author":"A Abhishek","year":"2016","unstructured":"Abhishek, A., Valdes, A. M. & Doherty, M. Low omega-3 fatty acid levels associate with frequent gout attacks: a case control study. Ann. Rheum. Dis. 75, 784\u2013785 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017155_CR47","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Y Yan","year":"2013","unstructured":"Yan, Y. et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38, 1154\u20131163 (2013).","journal-title":"Immunity"},{"key":"BFnrrheum2017155_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","volume":"17","author":"TR Merriman","year":"2015","unstructured":"Merriman, T. R. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res. Ther. 17, 98 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2017155_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13075-015-0802-3","volume":"17","author":"C McKinney","year":"2015","unstructured":"McKinney, C. et al. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Res. Ther. 17, 288 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2017155_CR50","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1177\/0961203316644336","volume":"25","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H. & Bae, S. C. Association between functional NLRP3 polymorphisms and susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Lupus 25, 1558\u20131566 (2016).","journal-title":"Lupus"},{"key":"BFnrrheum2017155_CR51","doi-asserted-by":"publisher","first-page":"e64845","DOI":"10.1371\/journal.pone.0064845","volume":"8","author":"YF Qing","year":"2013","unstructured":"Qing, Y. F. et al. Association of TLR4 gene rs2149356 polymorphism with primary gouty arthritis in a case-control study. PLoS ONE 8, e64845 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2017155_CR52","doi-asserted-by":"publisher","first-page":"e0147939","DOI":"10.1371\/journal.pone.0147939","volume":"11","author":"H Rasheed","year":"2016","unstructured":"Rasheed, H. et al. The Toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and Polynesian sample sets. PLoS ONE 11, e0147939 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2017155_CR53","first-page":"457","volume":"56","author":"WC Chang","year":"2017","unstructured":"Chang, W. C. et al. Genetic variants of PPAR-\u03b3 coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis. Rheumatology (Oxford) 56, 457\u2013466 (2017).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2017155_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/icb.2009.98","volume":"88","author":"O Popa-Nita","year":"2010","unstructured":"Popa-Nita, O. & Naccache, P. H. Crystal-induced neutrophil activation. Immunol. Cell Biol. 88, 32\u201340 (2010).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrrheum2017155_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nm.3547","volume":"20","author":"C Schauer","year":"2014","unstructured":"Schauer, C. et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat. Med. 20, 511\u2013517 (2014).","journal-title":"Nat. Med."},{"key":"BFnrrheum2017155_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/eji.201545605","volume":"46","author":"J Desai","year":"2016","unstructured":"Desai, J. et al. PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1\u2013RIPK3\u2013MLKL signaling. Eur. J. Immunol. 46, 223\u2013229 (2016).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2017155_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","volume":"45","author":"D Carling","year":"2017","unstructured":"Carling, D. AMPK signalling in health and disease. Curr. Opin. Cell Biol. 45, 31\u201337 (2017).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrrheum2017155_CR58","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","volume":"75","author":"Y Wang","year":"2016","unstructured":"Wang, Y., Viollet, B., Terkeltaub, R. & Liu-Bryan, R. AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages. Ann. Rheum. Dis. 75, 286\u2013294 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017155_CR59","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/art.1780390718","volume":"39","author":"F Liote","year":"1996","unstructured":"Liote, F. et al. Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor \u03b21. Arthritis Rheum. 39, 1192\u20131198 (1996).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017155_CR60","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1136\/ard.2010.145821","volume":"70","author":"YH Chen","year":"2011","unstructured":"Chen, Y. H. et al. Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGF\u03b21, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann. Rheum. Dis. 70, 1655\u20131663 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017155_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/eji.201646551","volume":"47","author":"I Galvao","year":"2017","unstructured":"Galvao, I. et al. Annexin A1 promotes timely resolution of inflammation in murine gout. Eur. J. Immunol. 47, 585\u2013596 (2017).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2017155_CR62","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","volume":"167","author":"R Ter Horst","year":"2016","unstructured":"Ter Horst, R. et al. Host and environmental factors influencing individual human cytokine responses. Cell 167, 1111\u20131124.e13 (2016).","journal-title":"Cell"},{"key":"BFnrrheum2017155_CR63","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/annrheumdis-2014-206966","volume":"75","author":"LA Joosten","year":"2016","unstructured":"Joosten, L. A. et al. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1\u03b2 and by the induction of endogenous IL-1Ra. Ann. Rheum. Dis. 75, 1219\u20131227 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017155_CR64","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1136\/ard.2008.096693","volume":"68","author":"AJ Elliot","year":"2009","unstructured":"Elliot, A. J., Cross, K. W. & Fleming, D. M. Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994\u20132007. Ann. Rheum. Dis. 68, 1728\u20131733 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017155_CR65","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa, T. et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 14, 454\u2013460 (2013).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2017155_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm, Y. H. et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263\u2013269 (2015).","journal-title":"Nat. Med."},{"key":"BFnrrheum2017155_CR67","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","volume":"18","author":"EL Goldberg","year":"2017","unstructured":"Goldberg, E. L. et al. \u03b2-Hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep. 18, 2077\u20132087 (2017).","journal-title":"Cell Rep."},{"key":"BFnrrheum2017155_CR68","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/mnfr.201600106","volume":"60","author":"JJ Jhang","year":"2016","unstructured":"Jhang, J. J., Lu, C. C. & Yen, G. C. Epigallocatechin gallate inhibits urate crystals-induced peritoneal inflammation in C57BL\/6 mice. Mol. Nutr. Food Res. 60, 2297\u20132303 (2016).","journal-title":"Mol. Nutr. Food Res."},{"key":"BFnrrheum2017155_CR69","doi-asserted-by":"publisher","first-page":"e0145093","DOI":"10.1371\/journal.pone.0145093","volume":"10","author":"C Dhanasekar","year":"2015","unstructured":"Dhanasekar, C., Kalaiselvan, S. & Rasool, M. Morin, a bioflavonoid suppresses monosodium urate crystal-induced inflammatory immune response in RAW 264.7 macrophages through the inhibition of inflammatory mediators, intracellular ROS levels and NF-\u03baB activation. PLoS ONE 10, e0145093 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2017155_CR70","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10753-015-0271-5","volume":"39","author":"SK Kim","year":"2016","unstructured":"Kim, S. K., Choe, J. Y. & Park, K. Y. Rebamipide suppresses monosodium urate crystal-induced interleukin-1\u03b2 production through regulation of oxidative stress and caspase-1 in THP-1 cells. Inflammation 39, 473\u2013482 (2016).","journal-title":"Inflammation"},{"key":"BFnrrheum2017155_CR71","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1038\/ncomms7555","volume":"6","author":"A Ives","year":"2015","unstructured":"Ives, A. et al. Xanthine oxidoreductase regulates macrophage IL-1\u03b2 secretion upon NLRP3 inflammasome activation. Nat. Commun. 6, 6555 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrrheum2017155_CR72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3565(24)29317-4","volume":"299","author":"DG Perregaux","year":"2001","unstructured":"Perregaux, D. G. et al. Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors. J. Pharmacol. Exp. Ther. 299, 187\u2013197 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrrheum2017155_CR73","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248\u2013255 (2015).","journal-title":"Nat. Med."},{"key":"BFnrrheum2017155_CR74","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","volume":"197","author":"MJ Primiano","year":"2016","unstructured":"Primiano, M. J. et al. Efficacy and pharmacology of the NLRP3 inflammasome inhibitor CP-456,773 (CRID3) in murine models of dermal and pulmonary inflammation. J. Immunol. 197, 2421\u20132433 (2016).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017155_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"W Wannamaker","year":"2007","unstructured":"Wannamaker, W. et al. (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoy l)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1\u03b2 and IL-18. J. Pharmacol. Exp. Ther. 321, 509\u2013516 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrrheum2017155_CR76","first-page":"111","volume":"34","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. & Zheng, Y. Effects and mechanisms of potent caspase-1 inhibitor VX765 treatment on collagen-induced arthritis in mice. Clin. Exp. Rheumatol. 34, 111\u2013118 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017155_CR77","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1002\/art.25006","volume":"60","author":"LA Joosten","year":"2009","unstructured":"Joosten, L. A. et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1\u03b2. Arthritis Rheum. 60, 3651\u20133662 (2009).","journal-title":"Arthritis Rheum."},{"issue":"Suppl.","key":"BFnrrheum2017155_CR78","first-page":"S402","volume":"63","author":"R Alten","year":"2011","unstructured":"Alten, R. et al. Efficacy of canakinumab on re-treatment in gouty arthritis patients with limited treatment options: 24-week results from \u03b2-RELIEVED and \u03b2-RELIEVED-II [abstract]. Arthritis Rheum. 63 (Suppl.), S402 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017155_CR79","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847\u2013856 (2008).","journal-title":"Nat. Immunol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2017.155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2017.155","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrrheum.2017.155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2017.155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:57:06Z","timestamp":1750877826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2017.155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,28]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFnrrheum2017155"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2017.155","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,28]]},"assertion":[{"value":"28 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.K.S. declares that he has acted as a consultant for AstraZeneca, Menarini and Novartis. F.M. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}